top of page
MemorisesBio_logo_transparent.png

Our Story

MEMORISES Bio was carved-out from the team and technology behind
MEMO Therapeutics AG and carries forward a proven discovery platform to unlock

the next wave of immune-derived medicines.

Team

Director
BOARD OF DIRECTORS
John Smith
John Smith
Director
John Smith
Director
LAB

Platform

Projects

Recombinant  polyclonal 
Immunoglobulins

Trusted by the industry's trailblazers

Client Logos

Elevate Your Enterprise

Move beyond manual tasks and focus on strategic growth

Enhance Decision-Making

02

Transform raw data into strategic intelligence. Our predictive engine provides the visibility required to make impactful business pivots with absolute certainty.

Scale with Confidence

03

Architecture engineered for the future. Effortlessly integrate evolving tech stacks and maintain a single source of truth as your enterprise scales vertically and horizontally.

Accelerate Productivity

01

Eliminate manual operational friction and optimize resource allocation with intelligent automation that adapts to your team's specific growth objectives.

recording-1777024605745.mp4

See OtherSync in action

Experience firsthand how our platform can transform your operations. Schedule a personalized demo with our experts today.

Request a Demo

Translating unique human immune responses
into next-generation antibody therapeutics​

Superior capture

Dropzilla® platform secures 80% of antibody repertoire recovery in a sample. 

Better antibodies

Greater diversity increases the chances of finding the best therapeutic lead.

For any condition

Powers target-agnostic antibody discovery for all diseases.

bottom of page